---

Robin Robinson

Retired

During his time as Director of Biomedical Advanced Research Development Authority (BARDA), Robin developed patented platform vaccine technologies including virus-like particles and subunit protein vaccines for human pathogens – and led the development of the first avian influenza H5N1 vaccine. Robin has also served on WHO international expert teams on influenza vaccines.

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018